Submit a Story!
P&G Sells Drug Unit for $3.1 Billion
P&G Sells Drug Unit for $3.1 Billion
Procter & Gamble said Monday that it agreed to sell its pharmaceuticals unit to Warner Chilcott for $3.1 billion in cash, as P&G seeks to focus on its consumer health and personal care businesses.
What’s Wrong With P&G?
What’s Wrong With P&G?
dividendsvalue.com — Product demand for household and personal care products is generally stable and not affected by changes in... the economy or geopolitical factors. Investors know this and when the economy and the market turn down, many investors start buying defensive stocks . Since the end of the year, ... (more) What’s Wrong With P&G?
Warner Chilcott to Buy Procter & Gamble Unit
dealbook.blogs.nytimes.com — Warner Chilcott has agreed to buy Procter & Gamble's prescription drug business, people briefed on the matter... told DealBook on Sunday. (more) Warner Chilcott to Buy Procter & Gamble Unit
Comments
Blog Reactions

Monday links: preferential access
Abnormal Returns — ... Options) Checking out Bank of America (BAC) and a new charting service.  (VIX and More) Technical analysis-based mutual funds double in number.  (Fund My Mutual Fund) Just how big is the high frequency trading business?  (Clusterstock) Are deals backed by leveraged loans back?  (FT Alphaville, DealBook) The TARP seems to be turning a profit. ...

Related: warner chilcott pharmaceuticals
Closing Bell: A coin-toss of a trading day (WCRX, PG, FNM, FRE, ARIA, MELA, SHLD)BloggingStocks
Today was starting out as another one of those irrational exuberance days with shares gaining, despite a Nouriel Roubini panning of the economy for a double-dip recession . But when you factor in Meredith Whitney comments and Dick Bove calling for more bank closures, the sellers put a lid on ...